Serina Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 |
|---|---|
| Operating Activities | |
| Net Income | $-6.6M |
| Depreciation & Amortization | — |
| Depreciation | $165.0K |
| Amortization | $517.0K |
| Stock-Based Compensation | $114.0K |
| Net Cash from Operating Activities | $-6.3M |
| Investing Activities | |
| Capital Expenditures | $1.0K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $5.0K |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $13.3M |
| Net Change in Cash | $7.1M |
| Free Cash Flow | $-6.3M |